About this Event
Amid social distancing and other on-the-ground mitigation measures, arises the necessity of a vaccine and other therapeutic treatments for long-term treatment or eradication of COVID-19. With drug development comes questions of safety and efficacy, and inevitable concerns around human subject research. This briefing will explore the legal issues around how to balance speed to market, obligations to science and an ethical development process.
GUESTS
Jennifer Bard, Visiting Professor of Law, University of Florida
Holly Fernandez Lynch, Presidential Assistant Professor of Medical Ethics, Perelman School of Medicine, University of Pennsylvania
HOST
Scott Burris, Professor and Director, Center for Public Health Law Research at Temple University’s Beasley School of Law
Wednesday, May 6 | 12:00 - 1:00 PM |
0 people are interested in this event
User Activity
No recent activity